References Considered by Dr. Lutz Riechmann
`
`Exhibit No.
`
`1001
`
`Description
`
`U.S. Patent No. 6,407,213, Method for making humanized
`antibodies (filed Jul. 17, 1993) (issued June 18, 2002)
`
`1002 Part I
`
`File History for U.S. Patent No. 6,407,213 Part I
`
`1002 Part II
`
`File History for U.S. Patent No. 6,407,213 Part II
`
`
`
`
`
`
`
`
`
`
`
`
`1003
`
`1003A
`
`1003B
`
`1003C
`
`1004
`
`1004A
`
`1004B
`
`1021
`
`1022
`
`1030
`
`1031
`
`Declaration of Dr. Eduardo A. Padlan in Support of Petition for
`Inter Partes Review of Patent No. 6,407,213
`
`Curriculum Vitae of Dr. Eduardo A. Padlan
`
`Materials Reviewed by Dr. Eduardo A. Padlan
`
`Exhibits A-M of Dr. Eduardo A. Padlan
`
`Declaration of Professor Edward Ball, M.D. in Support of
`Petition for Inter Partes Review of Patent No. 6,407,213
`
`Curriculum Vitae of Professor Edward Ball, M.D.
`
`Materials Reviewed by Professor Edward Ball, M.D.
`
`Hudziak et al. p185HER2 Monoclonal Antibody Has
`Antiproliferative Effects In Vitro and Sensitizes Human Breast
`Tumor Cells to Tumor Necrosis Factor. Mol. Cell Biol.
`9(3):1165-1172 (March 1989)
`
`Köhler and Milstein, Continuous Cultures of Fused Cells
`Secreting Antibody of Predefined Specificity. Nature
`256(5517):495-497 (August 7, 1975)
`
`“Protein Data Bank – Chronology” at
`https://www.nsf.gov/news_summ.jsp?cntn_id=100689 (accessed
`August 29, 2016)
`
`Morrison et al., Chimeric Human Antibody Molecules: Mouse
`Antigen-Binding Domains with Human Constant Region
`
`
`
`
`
`1 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`1001
`
`Description
`
`U.S. Patent No. 6,407,213, Method for making humanized
`antibodies (filed Jul. 17, 1993) (issued June 18, 2002)
`
`1002 Part I
`
`File History for U.S. Patent No. 6,407,213 Part I
`
`1002 Part II
`
`File History for U.S. Patent No. 6,407,213 Part II
`
`
`
`
`
`
`
`
`
`
`
`
`1003
`
`1003A
`
`1003B
`
`1003C
`
`1004
`
`1004A
`
`1004B
`
`1021
`
`1022
`
`1030
`
`1031
`
`Declaration of Dr. Eduardo A. Padlan in Support of Petition for
`Inter Partes Review of Patent No. 6,407,213
`
`Curriculum Vitae of Dr. Eduardo A. Padlan
`
`Materials Reviewed by Dr. Eduardo A. Padlan
`
`Exhibits A-M of Dr. Eduardo A. Padlan
`
`Declaration of Professor Edward Ball, M.D. in Support of
`Petition for Inter Partes Review of Patent No. 6,407,213
`
`Curriculum Vitae of Professor Edward Ball, M.D.
`
`Materials Reviewed by Professor Edward Ball, M.D.
`
`Hudziak et al. p185HER2 Monoclonal Antibody Has
`Antiproliferative Effects In Vitro and Sensitizes Human Breast
`Tumor Cells to Tumor Necrosis Factor. Mol. Cell Biol.
`9(3):1165-1172 (March 1989)
`
`Köhler and Milstein, Continuous Cultures of Fused Cells
`Secreting Antibody of Predefined Specificity. Nature
`256(5517):495-497 (August 7, 1975)
`
`“Protein Data Bank – Chronology” at
`https://www.nsf.gov/news_summ.jsp?cntn_id=100689 (accessed
`August 29, 2016)
`
`Morrison et al., Chimeric Human Antibody Molecules: Mouse
`Antigen-Binding Domains with Human Constant Region
`
`
`
`
`
`1 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1033
`
`1034
`
`1045
`
`1046
`
`1047
`
`1048
`
`1049
`
`1050
`
`1051
`
`1052
`
`Description
`Domains. Pro. Nat’l Acad. Sci. 81:6851-6855 (November 1984).
`
`Jones et al. Replacing the Complementarity-Determining Regions
`in a Human Antibody with those from a Mouse. Nature 321:522-
`525 (1986)
`
`Queen et al. A Humanized Antibody that Binds to the Interleukin
`2 Receptor. Pro. Nat’l Acad. Sci. 86:10029-10033 (1989)
`
`Slamon, D.J. et al. Human Breast Cancer Correlation of Relapse
`and Survival with Amplification of the HER-2/neu Oncogene.
`Science 235:177-182 (1987)
`
`Kraus, M.H., et al. Overexpression of the EGF receptor-related
`proto-oncogene erbB-2 in human mammary tumor cell lines by
`different molecular mechanisms. The EMBO Journal 6(3):605-
`610 (1987)
`
`Hudziak, R. M., et al. Increased expression of the putative
`growth factor receptor p185HER2 causes transformation and
`tumorigenesis of NIH 3T3 cells. Pro. Nat’l Acad. Sci. 84:7159-
`7163 (1987)
`
`Shepard, H. M. et al. Monoclonal Antibody Therapy of Human
`Cancer: Taking the HER2 Protooncogene to the clinic. Journal
`of Clinical Immunology, 11(3):117-127 (1991).
`
`Chothia, C. et al. Conformations of immunoglobulin
`hypervariable regions. Nature 342(21):877-883 (December
`1989).
`
`Queen, Cary L.: International Publication No. WO 1990/07861
`(published July 26, 1990)
`
`Tramontano, A. et al. Framework Residue 71 is a Major
`Determinant of the Position and Conformation of the Second
`Hypervariable Region in the VH Domains of Immunoglobulins, J.
`Mol. Biol. 215:175-182 (1990)
`Kabat, et al. Sequences of Proteins of Immunological Interest 4th
`
`
`
`
`
`
`2 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`
`
`1053
`
`1055
`
`1057
`
`1058
`
`1059
`
`1060
`
`1061
`
`1062
`
`1063
`
`Description
`Ed., Tabulation and Analysis of Amino Acid and Nucleic Acid
`Sequences of Precursors, V-Regions, C-Regions, J-Chain, T-Cell
`Receptor for Antigen, T-Cell Surface Antigens (National
`Institutes of Health, Bethesda, Md.) (1987)
`
`Wu and Kabat, An analysis of the sequences of the variable
`regions of Bence Jones proteins and myeloma light chains and
`their implications for antibody complementarity. J. Exp. Med.
`132:211-250 (1970)
`Kabat, et al. Sequences of Proteins of Immunological Interest 5th
`Ed., Tabulation and Analysis of Amino Acid and Nucleic Acid
`Sequences of Precursors, V-Regions, C-Regions, J-Chain, T-Cell
`Receptor for Antigen, T-Cell Surface Antigens (National
`Institutes of Health, Bethesda, Md.) (1991)
`
`Johnson and Wu The Kabat database and a bioinformatics
`example, Methods in Molecular Biology 248:11-25 (December
`2003)
`
`Davies & Metzger, Structural Basics of Antibody Function,
`Annu. Rev. Immunol. 1:87-117 (1983)
`
`Amit et al. Three-Dimensional Structure of an Antigen-Antibody
`Complex at 2.8 A Resolution Science 233:747-53 (1986)
`
`Lascombe et al. Three-dimensional Structure of Fab R19.9, a
`Monoclonal Murine Antibody Specific for the p-
`azobenzenearsonate group. Pro. Nat’l Acad. Sci. 86:607-611
`(January 1989)
`
`Novotný et al. Molecular Anatomy of the Antibody Binding Site.
`J. Biol. Chem. 258(23):14433-14437 (December 10, 1983)
`
`Chothia & Lesk 1987, Canonical structures for the hypervariable
`regions of immunoglobulins. J. Mol. Biol. 196:901-917 (1987)
`
`Chothia et al. Domain Association in Immunoglobulin
`Molecules: The Packing of Variable Domains. J. Mol. Biol.
`186:651-63 (1985)
`
`
`
`
`
`3 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`Description
`
`1064
`
`1065
`
`1066
`
`1067
`
`1068
`
`1069
`
`1070
`
`1071
`
`1072
`
`1073
`
`Van Kroonenburgh & Pauwels Human Immunological Response
`to Mouse Monoclonal Antibody Treatment or Diagnosis of
`Malignant Diseases. Nucl. Med. Commun. 9:919-30 (1988)
`
`Tjandra et al. Development of human anti-murine antibody
`(HAMA) response in patients. Immunol. Cell. Biol. 68:367-76
`(1990)
`
`Lind, et al. Development of human antimouse antibodies
`(HAMA) after single and repeated diagnostic application of
`intact murine monoclonal antibodies. Antibod. Immunoconj.
`Radiopharm. 4(4):811-818 (1991)
`
`Mountain and Adair, Engineering Antibodies for Therapy.
`Biotech. Genet. Eng. Rev. 10:1-142 (1992)
`
`Verhoeyen, Milstein & Winter et al. Reshaping Human
`Antibodies: Grafting an Antilysozyme Activity. Science
`239:1534- 1536 (March 25, 1988)
`
`Riechmann, et al. Reshaping human antibodies for therapy.
`Nature 332:323-327 (March 24, 1988)
`
`Tempest, et al. Reshaping a human monoclonal antibody to
`inhibit human respiratory syncytial virus infection in vivo.
`BioTechnology 9:266-271 (March 1991)
`
`Kurrle, et al. Improved monoclonal antibodies against the human
`alphabeta T-Cell receptor, their production and use. EP0403156.
`(1990)
`
`Shearman, et al. Construction, expression and characterization of
`humanized antibodies directed against the human a/b T cell
`receptor. J. Immunol. 147(12):4366-4373, (December 15, 1991)
`
`Winter, Gregory Paul et al. EP Publication Number 0239400,
`Recombinant antibodies and methods for their productions.
`Published September 30, 1987.
`
`
`
`
`
`4 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`Description
`
`1076
`
`1077
`
`1078
`
`1079
`
`1080
`
`1081
`
`1082
`
`1083
`
`1085
`
`1086
`
`Loew, G. et al. Engergy-Conformational Studies of B-Endorphis:
`Identification of Plausible Folded Conformers. Int. J. Quant.
`Chem. Quant. Biol. 15:55-66 (1988)
`
`Bruccoleri et al. Structure of antibody hpervariable loops
`reproduced by a conformational search algorithm. Nature
`335(6):564-568 (1988)
`
`Chothia et al. The Predicted Structure of Immunoglobulin D1.3
`and its Comparison with the Crystal Structure. Science New
`Series, 233(4765):755-758 (August 15, 1986)
`
`Kabat et al., Sequences of Proteins of Immunological Interest
`Tabulation and Analysis of Amino Acid and Nucleic Acid
`Sequences of Precursors, V-Regions, C-Regions, J-Chain, T-Cell
`Receptor for Antigen, T-Cell Surface Antigens (National
`Institutes of Health, Bethesda, Md.) (1983).
`
`Bernstein et al. The Protein Data Bank: A Computer-based
`Archival File for Macromolecular Structures. J. Mol. Biol.
`112:535-542 (1977)
`
`Sheriff et al. Three-Dimensional Structure of an Antibody-
`Antigen Complex, Proc. Nat’l Acad. Sci. U.S.A. 84:8075 (1987)
`
`Marquart et al. The three-dimensional structure of antibodies.
`Immun. Today 3(6):160-166 (1982)
`
`Saul et al. Preliminary Refinement and Structural Analysis of the
`FAB Fragment from Human Immunoglobulin NEW at 2.0
`Angstroms Resolution. J. Biol. Chem. 253:585 (1978)
`
`Satow et al. Phosphocholine Binding Immunogloubulin Fab
`McPC306 An X-ray Diffraction Study at 2•Å. J. Mol. Biol.
`190:593-604 (1986)
`
`Herron et al. Three-Dimensional Structure of a Flourescein-Fab
`Complex Crystallized in 2-Methyl-2,4-pentanediol. Proteins
`5:271-280 (1989)
`
`
`
`
`
`5 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`Description
`
`1087
`
`1088
`
`1089
`
`1090
`
`1091
`
`1092
`
`1097
`
`1098
`
`1099
`
`1100
`
`Padlan et al. Structure of an antibody-antigen complex: crystal
`structure of the HYHEL-10 FAB-lysozyme complex. Proc. Nat’l
`Acad. Sci. 86:5938-5942 (August 1989)
`
`Kumar et al. Regulation of phosphorylation of the c-erbB-
`2/HER2 gene product by monoclonal antibody and serum growth
`factor(s) in human mammary carcinoma cells. Mol. Cell. Biol.
`11(2):979-986 (February 1991)
`
`Soomro et al. C-erbB-2 expression in different histological types
`of invasive breast carcinoma. J. Clin. Pathol. 44:211-14 (1991)
`
`Keith Wilson & Kenneth H. Goulding, A Biologist’s Guide to
`Principles and Techniques of Practical Biochemistry, §Protein
`sequencing, 170-173 (3rd ed., 1986)
`
`Edelman et al. The Covalent Structure of an Entire γG
`Immunoglobulin Molecule. Proc. Nat’l Acad. Sci 63:78-85
`(1969)
`
`Capra, J. Donald and Kehoe, K. Michael Variable Region
`Sequences of Five Human Immunoglobulin Heavy Chains of the
`VHIII Subgroup: Definitive Identification of Four Heavy Chain
`Hypervariable Regions. Proc. Nat’l Acad. Sci. 71:845-8 (1974)
`
`Sambrook et al., Molecular Cloning (2d ed., Cold Spring Harbor
`Laboratory Press) (1989)
`
`Daugherty et al., Polymerase chain reaction facilitates the
`cloning, CDR-grafting and rapid expression of a murine
`monoclonal antibody directed against the CD18 component of
`leukocyte integrins. Nucl. Acids Res. 19(9):2471-2476 (May
`1991).
`
`Padlan and Kabat, Modeling of Antibody Combining Sites Meth.
`Enzymol. 203:3 (1991)).
`
`Colman et al., Three-dimensional structure of a complex of
`antibody with influenza virus neuraminidase, Nature 326:358
`
`
`
`
`
`6 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`Description
`
`
`
`1101
`
`1102
`
`1103
`
`1104
`
`1105
`
`1106
`
`1107
`
`1108
`
`1109
`
`1110
`
`(1987)
`
`Tulip et al., Crystal structures of neuraminidase-antibody
`complexes, Cold Spring Harbor Symp. Quant. Biol. 4:257 (1989)
`
`Bender et al., Immunogenicity, efficacy and adverse events of
`adalimumab in RA patients. Rheumatol. Int. 27:269-74 (2007)
`
`Brient, Bruce W. and Nisonoff, Alfred Quantitative
`investigations of idiotypic antibodies. IV. Inhibition by specific
`haptens of the reaction of anti-hapten antibody with its anti-
`idiotypic antibody, J Exp Med. 132:951-62 (1970)
`
`Koprowski et al., Human anti-idiotype antibodies in cancer
`patients: Is the modulation of the immune response beneficial for
`the patient? Proc. Nat’l. Acad. Sci. U.S.A. 81:216 (1984)
`
`Chanh et al., Monoclonal anti-idiotypic antibody mimics the CD4
`receptor and binds human immunodeficiency virus, Proc. Nat’l.
`Acad. Sci. U.S.A. 84:3891 (1987)
`
`Schroff et al., Human Anti-Murine Immunoglobulin Responses in
`Patients Receiving Monoclonal Antibody Therapy, Cancer Res.
`45:879 (1985)
`
`Abdou et al., Network Theory in Autoimmunity. In vitro
`suppression of serum anti-DNA by anti-idiotypic antibody in
`systemic lupus erythematosus, J. Clin. Invest. 67:1297 (1981)
`
`Harris, L.J. et al. The three-dimensional structure of an intact
`monoclonal antibody for canine lymphoma, Nature 360:369-72
`(1992)
`
`Janeway, C.A. et al., IMMUNOBIOLOGY: THE IMMUNE SYSTEM IN
`HEALTH & DISEASE (4th ed., Garland Science Publishing, NY,
`(1999))
`
`Potter, M. Immunoglobulin-producing tumors and myeloma
`proteins of mice, Physiol. Rev. 52:631-719 (1972)
`
`
`
`
`
`7 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`Description
`
`1111
`
`1112
`
`1113
`
`1114
`
`1115
`
`1116
`
`1117
`
`1118
`
`1119
`
`1120
`
`Kabat K.A. and Wu, T.T. Attempts to locate complementarity-
`determining residues in the variable positions of light and heavy
`chains Ann. NY Acad. Sci. 190:382-93 (1971);
`
`D.R. Davies et al. Antibody-antigen complexes, Ann. Rev.
`Biochem. 59:439-73 (1990).
`
`Epp et al., The molecular structure of a dimer composed of the
`variable portions of the Bence Jones protein REI refined at 2.0Å
`resolution, Biochem. 14:4943 (1975)
`Mian, I.S. Structure, function and properties of antibody binding
`sites, J. Mol. Biol. 217:133-51 (1991)
`
`Poljak et al. The three-dimensional structure of the fab fragment
`of a human myeloma immunoglobulin at 2.0-angstrom resolution,
`Proc. Nat’l Acad. Sci. U.S.A. 71:3440-4 (1974)
`
`Padlan et al. Model building studies of antigen binding sites: The
`hapten binding site of MOPC315 Cold Spring Harbor Symp.
`Quant. Biol. 41:627-37 (1977))
`
`Boulianne et al. Production of functional chimaeric
`mouse/human antibody, Nature 312:643-6 (1984)
`
`Padlan, E.A. A possible procedure for reducing the
`immunogenicity of antibody variable domains while preserving
`their ligand-binding properties, Mol. Immunol. 28:489-98 (1991)
`
`U.S. Patent No. 6,797,492 Method for Reducing the
`Immunogenicity of Antibody Variable Domains (veneering of
`CD18 monoclonal antibodies) (Filed March 16, 2001)(Issued
`September 28, 2004)
`
`Padlan, Eduardo A., Choosing The Best Framework To Use In
`The ‘Humanization’ Of An Antibody by CDR-Grafting:
`Suggestions From 3-D Structural Data. The 2nd Annual IBC
`International Conference on Antibody Engineering. Omni San
`Diego Hotel, San Diego, CA. (December 16-18, 1991)
`
`
`
`
`
`8 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`Description
`
`1121
`
`1122
`
`1123
`
`1124
`
`1125
`
`1126
`
`1127
`
`1128
`
`1129
`
`1130
`
`Suh et al., The galactan-binding immunoglobulin Fab J539: an
`X-ray diffraction study at 2.6-Å resolution, Proteins 1:74 (1986)
`
`U.S. Patent No. 5,792,852 Polynucleotides Encoding Modified
`Antibodies with Human Milk Fat Globule Specificity
`(humanization of monoclonal antibodies binding to human milk
`fat globule antigen) (Filed November 16, 1992) (Issued August
`11, 1998)
`
`U.S. Patent No. 5,889,157 Humanized B3 Antibody Fragments,
`Fusion Proteins, and Uses Thereof (humanization of monoclonal
`antibodies to Lewisϒ-related carbohydrate antigen) (Filed
`October 28, 1994) Issued March 30, 1999)
`
`US Patent No. 5,795,965 Reshaped human antibody to human
`interleukin-6 receptor (claiming priority to April 25, 1991)
`(Issued August 18, 1998)
`
`Furey et al. Structure of a novel Bence-Jones protein (Rhe)
`fragment at 1.6 Å resolution, J. Mol. Biol. 167:661-92 (1983)
`
`Segal et al. The Three-Dimensional Structure of a
`Phosphorylcholine-Binding Mouse Immunoglobulin Fab and the
`Nature of the Antigen Binding Site, Proc. Nat’l Acad. Sci. U.S.A.
`71:4298 (1974)
`
`Jones, TA Diffraction methods for biological macromolecules.
`Interactive computer graphics: FRODO, Meth. Enzymol.
`115:157-71 (1985)
`
`Co, M. et al. Humanized antibodies for antiviral therapy, Proc.
`Nat’l Acad. Sci. U.S.A. 88:2869-73 (1991)
`
`http://www.exceltrick.com/others/history-of-excel/ (accessed
`August 29, 2016)
`
`U.S. Patent No. 4,891,762 Method and Apparatus for Tracking,
`Mapping and Recognition of Spatial Patterns (Filed February 9,
`1988) (Issued January 2, 1990)
`
`
`
`
`
`9 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
`
`Exhibit No.
`
`Description
`
`1131
`
`1132
`
`Wallick, S. et al. Glycosylation of a VH residue of a monoclonal
`antibody against α(1-6) dextran increases its affinity for antigen,
`J. Exp. Med. 168:1099-109 (1988)
`
`Hale, G. et al. Remission Induction in Non-Hodgkin Lymphoma
`with Reshaped Human Monoclonal Antibody Campath-1H,
`Lancet, Vol. 2, 1394-1399 (1988).
`
`
`
`
`
`
`
`10 of 10
`
`Celltrion, Inc., Exhibit 1003B
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
